• Home
  • Global Regulatory Affairs Services
    • Introduction
    • Pharmaceutical
      • Requirements of Health Authorities
      • Drug Application Process
      • Meeting with Health Authorities
      • Electronic Common Technical Document (eCTD)
      • Register of Innovative Drugs
      • Submissions Comparing to Innovative Drugs
      • Product Monograph
      • Drug Label Compliance
      • Filing of Information and Material to Health Authorities
      • Evaluation of Submissions
      • Pharmacovigilance
    • Natural Health Products
      • NHP Documentation Review
      • NHP Product Registration Submissions
      • Natural Health Product Site Licence
    • Medical Device
      • Medical Devices Services
      • Medical Device Application Process
      • Medical Device class II, III and IV
  • Market Expansion Services
  • Contact Us
Atinza Canada Inc.Atinza Canada Inc.
  • Home
  • Global Regulatory Affairs Services
    • Introduction
    • Pharmaceutical
      • Requirements of Health Authorities
      • Drug Application Process
      • Meeting with Health Authorities
      • Electronic Common Technical Document (eCTD)
      • Register of Innovative Drugs
      • Submissions Comparing to Innovative Drugs
      • Product Monograph
      • Drug Label Compliance
      • Filing of Information and Material to Health Authorities
      • Evaluation of Submissions
      • Pharmacovigilance
    • Natural Health Products
      • NHP Documentation Review
      • NHP Product Registration Submissions
      • Natural Health Product Site Licence
    • Medical Device
      • Medical Devices Services
      • Medical Device Application Process
      • Medical Device class II, III and IV
  • Market Expansion Services
  • Contact Us

Meeting with Health Canada

Home PharmaceuticalMeeting with Health Canada

Technical Pre-Submission Consultation

For guidance and assistance for the filing process of eCTD

Sponsors filing a regulatory activity in eCTD format for the first time are recommended to request a technical pre-submission consultation with Health Canada. This consultation is held to clarify needs, responsibilities, and expectations, as well as to provide Health Canada the opportunity to offer assistance and guidance for the filing process in eCTD format. This consultation does not necessarily need to take place at the same time as the regulatory pre-submission meeting. To request a technical pre-submission consultation, contact Office of Submissions and Intellectual Property (OSIP).

Atinza will assist clients to submit necessary information to Health Canada prior to this meeting and can also accompany clients or act on behalf of clients to meet and discuss with Health Canada.

Pre-submission Meetings

Another meeting with Health Canada prior to submission

Sponsors may wish to deliver a brief presentation to the appropriate Directorate within Health Canada prior to filing a New Drug Submission (NDS), Supplement to a New Drug Submission (SNDS), Abbreviated New Drug Submission (ANDS), Clinical Trial Application (CTA), combination product classification request or request for Priority Review or NOC/c status.

Atinza will support clients to submit request for the meeting to appropriate Regulatory Affairs Division (BGTD) or Regulatory Project Manager (TPD). We will ensure the request contains all contents as per required by Health Canada and ensure that meetings are well-organized, efficient, productive, and properly documented.

Contact Us

Please let us know if you have any inquiries.

Send Message
Global Expertise in Regulatory Affairs Experienced & Results-Oriented

Atinza provides timely but yet effective regulatory affairs services for all stages of your products’ development and lifecycle management.



Page

Introduction

Pharmaceutical

Natural Health Products

Medical Device

 

QUICK LINKS

Introduction

Pharmaceutical

Natural Health Products

Medical Device

 

CONTACT US

© [2017] — Atinza Canada Inc. All rights reserved.